News wire
Drugs and medical devices
Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.
Source check 14 min ago · Newest item 10 hr ago · 1,441 stories this week · 85 of 90 publishers answering · Browse publishers · RSS feed
Filter stories (1)
Saved on this browser
Drugs and medical devices
Friday, October 2
Medivis Gets Some AR Device Patent Claims Cut In Remand
Fed. Circ. Affirms Corteva Unit IP Loss Days After Inari Deal
New DNA Screening Standard Has No Clear Playbook
Greenberg Traurig Adds Food, Drug Law Atty In DC
Class Cert. Denied In Planned Parenthood Tracking Tech Row
Thursday, October 1
NH Families Seek To Block Medicaid Ban On Youth Trans Care
Fed. Circ. Won't Rethink Vacating Contractor's $12.7M Award
Judge 'Flummoxed' By Forum Claim In IQVIA's Poaching Suit
Liquidia's Yutrepia Found To Infringe Lung Treatment Patent
Northwestern's IP License With Feds Doesn't Protect Moderna
Fla. AG Says Pfizer Hid COVID Vax Risks From Consumers
Read at Law360 Product Liability 2 publishers · 2 reports
Hernia Mesh Lawsuit
We Would Get Sanctioned If We Behaved Like That
Wednesday, September 30
Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature
The Food and Drug Administration (FDA) is classifying the flushing and storage solution for vascular autografts at room temperature into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the flushing and storage solution for vascular autografts at room temperature. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also…
Tuesday, September 29
Spinal Cord Stimulator Lawsuit
Country Roads and Curious Pleading Standards
Friday, September 25
Dismissal of Negligent Undertaking Claim in Massachusetts
Thursday, September 24
Dupixent Side Effects Lawsuit Alleges Drug Caused Cutaneous T-Cell Lymphoma
Cefepime Side Effects May Increase Risk of Death: Study
Wednesday, September 23
Early Alert: Ventilator Issue from React Health
IFT cable connector on VOCSN devices may become unseated and lose communication with internal flow transducer board leading to reboots, System Fault 10 Alarms.
Early Alert: Heart Pump Controller Issue from Abiomed
Abiomed is removing certain Impella Controllers with various hardware, firmware, and/or software updates based on a retrospective review of servicing records.
Monday, September 21
Lawsuit Alleges Oxbryta Vaso-Occlusive Crisis Caused Deadly Side Effects for 8-Year-Old
Ventilator Recall: CooperSurgical Removes INCA Infant Nasal CPAP Sets
The cannula sets may exhibit a loose connection between the flexible tubing and the nasal cannula resulting in reduced effectiveness and decreased oxygenation.
Saturday, September 19
Shameless Plug – The 31st Annual ACI Drug & Medical Device Litigation Conference
Friday, September 18
Sodium Chloride Flush Recall: Spectra Medical Removes Sodium Chloride Injection USP Ampules
Spectra Medical Devices is removing Sodium Chloride Flush products that were manufactured by Huons Co,. Ltd.
Nitric Oxide Delivery System Correction: NOxBOX Updates Use Instructions for NOxBOXi Nitric Oxide Delivery System
The NOxBOX NOxBOXi System may leak oxygen during inhaled nitric oxide therapy
Thursday, September 17
Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker
Tuesday, September 15
Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss
Friday, September 11
Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software
The Food and Drug Administration (FDA) is classifying the cardiovascular machine learning-based notification software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cardiovascular machine learning- based notification software. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access…
Connect the news to your market.
Research the firms, offices and conference relationships behind the headlines.